中国社区医师
中國社區醫師
중국사구의사
Chinese Community Doctors
2015年
34期
41-42
,共2页
功能性便秘%莫沙必利%培菲康%联合治疗%疗效观察
功能性便祕%莫沙必利%培菲康%聯閤治療%療效觀察
공능성편비%막사필리%배비강%연합치료%료효관찰
Functional constipation%Mosapride%Bifico%Combined treatment%Curative effect observation
目的：分析莫沙必利联合培菲康治疗功能性便秘的临床效果。方法：收治功能性便秘患者66例，随机分为试验组和对照组。试验组给予莫沙必利联合培菲康治疗，对照组给予莫沙必利治疗。对比观察两组患者临床疗效、复发率以及不良反应发生情况。结果：试验组治疗无效4例，对照组治疗无效16例，试验组治疗总有效率87.9%明显高于对照组的51.5%(P＜0.05)。试验组复发11例，对照组复发12例，试验组复发率37.9%，显著高于对照组的70.6%(P＜0.05)。两组患者均未出现严重的不良反应，肝肾功能检查没有明显异常。结论：莫沙必利联合培菲康治疗功能性便秘的临床效果良好，复发率较低，而且不良反应较轻。
目的：分析莫沙必利聯閤培菲康治療功能性便祕的臨床效果。方法：收治功能性便祕患者66例，隨機分為試驗組和對照組。試驗組給予莫沙必利聯閤培菲康治療，對照組給予莫沙必利治療。對比觀察兩組患者臨床療效、複髮率以及不良反應髮生情況。結果：試驗組治療無效4例，對照組治療無效16例，試驗組治療總有效率87.9%明顯高于對照組的51.5%(P＜0.05)。試驗組複髮11例，對照組複髮12例，試驗組複髮率37.9%，顯著高于對照組的70.6%(P＜0.05)。兩組患者均未齣現嚴重的不良反應，肝腎功能檢查沒有明顯異常。結論：莫沙必利聯閤培菲康治療功能性便祕的臨床效果良好，複髮率較低，而且不良反應較輕。
목적：분석막사필리연합배비강치료공능성편비적림상효과。방법：수치공능성편비환자66례，수궤분위시험조화대조조。시험조급여막사필리연합배비강치료，대조조급여막사필리치료。대비관찰량조환자림상료효、복발솔이급불량반응발생정황。결과：시험조치료무효4례，대조조치료무효16례，시험조치료총유효솔87.9%명현고우대조조적51.5%(P＜0.05)。시험조복발11례，대조조복발12례，시험조복발솔37.9%，현저고우대조조적70.6%(P＜0.05)。량조환자균미출현엄중적불량반응，간신공능검사몰유명현이상。결론：막사필리연합배비강치료공능성편비적림상효과량호，복발솔교저，이차불량반응교경。
Objective:To analyze the clinical curative effect of mosapride combined with bifico in the treatment of functional constipation.Methods:66 patients with functional constipation were selected.They were randomly divided into the experimental group and the control group.The experimental group was given mosapride combined with bifico treatment.The control group was given mosapride treatment.The clinical treatment curative effects,recurrence rates and adverse reactions of two groups were compared.Results:4 cases were ineffective in the experimental group.16 cases were ineffective in the control group.The treatment total effective rate was 51.5% in the experimental group,it was significantly higher than 51.5% of the control group(P<0.05).11 cases recurred in the experimental group,12 cases recurred in the control group.The recurrence rate of the experimental group was 37.9%,it was significantly higher than 70.6% of the control group(P<0.05).There were no serious adverse reactions in the two groups,and the liver and kidney function tests were not significantly abnormal.Conclusion:Mosapride combined with bifico in the treatment of functional constipation has a good clinical effect,a low recurrence rate,and lighter adverse reactions.
